Suppliers / Beximco Pharmaceuticals

Beximco Pharmaceuticals

Bangladesh 2 duplicate records merged Updated 9 July 2026

Beximco Pharmaceuticals is a finished-dose manufacturer based in Bangladesh. It appears in 110 regulatory filings across 14 regulators, without an active US DMF or CEP on file. Its filings concentrate with NAFDAC (NG), ARCSA (EC) and MINSA (CR). Its GMP standing is certified by ANVISA (Brazil), NAFDAC (NG) and EMA.

0
active US DMFs
0
valid CEPs
3
registered plants
110
filings across 14 regulators
These figures were checked against the regulators' own files on 25 July 2026
EU GMP
1 of 1 confirmed
Sources: EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Registered plants

Site FDA FEI
Gazipur, United Arab Emirates Not on file
GAZIPUR, Bangladesh Not on file
Gazipur, Nigeria Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
NAFDAC (NG) 26 2
ARCSA (EC) 19 None
MINSA (CR) 14 None
UZPHARM (UZ) 10 None
TMDA (TZ) 10 None
EFDA (ET) 7 None
ANVISA (Brazil) None 2
EMA None 1

Comparing suppliers?

Choose your molecules and target markets. Beximco Pharmaceuticals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates